175 related articles for article (PubMed ID: 30942460)
1. Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
Shi C; Yang Y; Zhang L; Zhang T; Yu J; Qin S; Gao Y
Oncol Rep; 2019 Jun; 41(6):3167-3178. PubMed ID: 30942460
[TBL] [Abstract][Full Text] [Related]
2. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
3. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
Liang B; Li Y; Wang T
Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
[TBL] [Abstract][Full Text] [Related]
4. Screening of MicroRNA Biomarkers Related to the Progression of Bladder Cancer.
Ding T; Yang B; Yang D; Zhang P; Zhu Y; Zheng J
Cancer Biother Radiopharm; 2022 Aug; 37(6):424-434. PubMed ID: 33661056
[No Abstract] [Full Text] [Related]
5. A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
Liu CP; Zhang JH; Zheng SC; Liu J; Guo JC
Oncol Rep; 2018 Nov; 40(5):2826-2835. PubMed ID: 30226624
[TBL] [Abstract][Full Text] [Related]
6. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
Qi Y; Lai YL; Shen PC; Chen FH; Lin LJ; Wu HH; Peng PH; Hsu KW; Cheng WC
Sci Rep; 2020 Dec; 10(1):22270. PubMed ID: 33335254
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
9. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
10. Identifying a miRNA signature for predicting the stage of breast cancer.
Yerukala Sathipati S; Ho SY
Sci Rep; 2018 Oct; 8(1):16138. PubMed ID: 30382159
[TBL] [Abstract][Full Text] [Related]
11. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
12. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
13. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Xu G; Zhang M; Zhu H; Xu J
Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
[TBL] [Abstract][Full Text] [Related]
14. A systematic study on dysregulated microRNAs in cervical cancer development.
He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
16. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.
Shen F; Zheng H; Zhou L; Li W; Liu J; Xu X
J Cell Physiol; 2019 May; 234(5):7004-7011. PubMed ID: 30362552
[TBL] [Abstract][Full Text] [Related]
18. A microRNA expression signature for cervical cancer prognosis.
Hu X; Schwarz JK; Lewis JS; Huettner PC; Rader JS; Deasy JO; Grigsby PW; Wang X
Cancer Res; 2010 Feb; 70(4):1441-8. PubMed ID: 20124485
[TBL] [Abstract][Full Text] [Related]
19. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).
González-Quintana V; Palma-Berré L; Campos-Parra AD; López-Urrutia E; Peralta-Zaragoza O; Vazquez-Romo R; Pérez-Plasencia C
Oncol Rep; 2016 Jan; 35(1):3-12. PubMed ID: 26530778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
